Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
Denis Leonardo Fontes JardimSherri Z MillisJeffrey S RossScott LippmanSiraj M AliRazelle KurzrockPublished in: The oncologist (2022)
Cyclin pathway activating alterations are common in urinary tract tumors, but frequency varies with histology and tumors sites. Co-occurrence of cyclin and FGFR pathway alterations may inform therapeutic opportunities.